Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Times Interest Earned came in at -$25.29 in Q4 2025, down 893.43% YoY from $3.19 in Q4 2024, and up 91.36% on a QoQ basis from -$292.69 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 2 years of Times Interest Earned data on file, last reported at -$25.29 in Q4 2025.
- Quarterly Times Interest Earned fell 893.43% year-over-year to -$25.29 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$34.45 (down 413.19% YoY) and the FY2025 annual result came in at -$4.5, down 302.94% from the prior year.
- Times Interest Earned improved to -$25.29 in Q4 2025, from -$292.69 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$2.55 in Q4 2024 to a low of -$292.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.50 Mn | 7.50 Mn | - | -1.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.29 |
| Sep 30, 2025 | -292.69 |
| Jun 30, 2025 | -115.55 |
| Mar 31, 2025 | -9.58 |
| Dec 31, 2024 | -2.55 |
| Sep 30, 2024 | -9.19 |
| Jun 30, 2024 | -19.34 |
| Mar 31, 2024 | -10.10 |